The RenoVō® and AlphaFlo® products are derived from placental tissues and hold great potential as regenerative products. RenoVō® was developed utilizing equine amniotic tissue and amniotic fluid while AlphaFlo® was developed utilizing canine amniotic tissue. The products contain either equine-specific or canine-specific exosomes, cytokines, growth factors, and extracellular matrix proteins with known anti-inflammatory, anti-fibrotic, immunomodulatory, and regenerative properties.